ALGER HEALTH Competition

AHSCX Fund  USD 13.36  0.17  1.29%   
The fund is listed under the Health category and is part of the Alger family. The entity is thematically classified as Healthcare Funds. Alger Health Sciences shares competitive overlap with ALGER MIDCAP, Alger Mid, ALGER SMALL, ALGER SMALL, and ALGER SMALL and similar firms. Gross margin gaps between ALGER HEALTH and its closest rivals often point to structural cost advantages.

Correlation: ALGER HEALTH vs ALGER SMALLCAP Details

Poor diversification
Across the chosen horizon, ALGER HEALTH and ALGER SMALLCAP show a correlation of 0.75 and fall into the Poor diversification bucket. In portfolio terms, the overlap shows how much shared movement remains after combining both positions.

Moving together with ALGER Mutual Fund

  0.77AMGOX Alger Mid CapPairCorr
  0.75ABLOX Alger Balanced PortfolioPairCorr
Specify up to 10 symbols:
Experienced investors tracking ALGER HEALTH's watch for mean reversion setups where price has deviated from its long-run average. Sentiment extremes, news events, or liquidity shocks are common catalysts for these temporary dislocations in ALGER HEALTH. Prices periodically overshoot their intrinsic value in both directions, creating mean reversion opportunities in ALGER HEALTH. The mean reversion signal is most useful when combined with fundamental confirmation for ALGER HEALTH's.
Hype
Prediction
LowEstimatedHigh
12.3313.3814.43
Details
Intrinsic
Valuation
LowRealHigh
12.4213.4714.52
Details
Naive
Forecast
LowNextHigh
12.2713.3214.38
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
12.9913.5014.01
Details
Peer comparison enriches ALGER HEALTH analysis by revealing how the company ranks against competitors. ALGER HEALTH's multiples must be compared to direct competitors to determine genuine value. Superior peer-relative performance is one of the strongest justifications for ALGER HEALTH's valuation premium. Cross-company comparison is essential to validate or challenge any investment thesis on Alger Health Sciences.

ALGER HEALTH Competition Correlation Matrix

Competition correlation for Alger Health Sciences matters because related securities often respond to the same industry, factor, or macro drivers even when their business stories differ. The business currently sits in the Health sector and the Large industry. In practical terms, lower correlation may offer better diversification while higher correlation may leave the portfolio more exposed to one shared driver.

Risk-Adjusted Indicators

ALGER HEALTH Mutual Fund can look attractive on recent price action while risk efficiency lags the peer group. Reviewing ALGER HEALTH's risk-adjusted indicators gives a clearer view of whether returns are being earned efficiently. These indicators are quantitative in nature and help investors evaluate volatility and risk-adjusted expected returns across different positions.

ALGER HEALTH Competitive Analysis

    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
AHSCX AMGAX AMGOX AOFYX AOFIX AOFAX AOFCX AAICX AAIZX AAIYX
 1.29 
13.36
ALGER
 0.66 
16.54
ALGER
 0.73 
22.10
Alger
 1.47 
21.33
ALGER
 1.48 
20.55
ALGER
 0.82 
19.56
ALGER
 1.50 
16.93
ALGER
 0.76 
15.77
Alger
 0.62 
16.21
Alger
 0.74 
16.09
ALGER
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Analysis
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Price To Sales
Cash Position Weight
Equity Positions Weight
Three Year Return
Net Asset
Price To Book
Five Year Return
Year To Date Return
One Year Return
Ten Year Return
Price To Earning
Day Typical Price
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Information Ratio
Value At Risk

ALGER HEALTH Competition Peer Performance Charts

How to Analyze ALGER HEALTH Against Peers

ALGER HEALTH's peer analysis compares ALGER HEALTH with related companies to put valuation, quality, and risk metrics in context. This helps determine whether recent performance is company-specific or broadly sector-driven. A practical workflow includes:
  • Set a relevant peer group: Include direct competitors and close alternatives with comparable business exposure.
  • Benchmark core financials: Compare profitability, growth, capital structure, and cash flow quality.
  • Check valuation dispersion: Review whether ALGER HEALTH trades at a premium or discount versus peers and why.
  • Evaluate risk profile: Compare volatility, drawdowns, and correlation to avoid false diversification assumptions.
  • Document the thesis: Record where ALGER HEALTH leads or lags and what catalysts could close or widen the gap.
Use this as an educational baseline, then validate conclusions with current filings, market conditions, and portfolio objectives.

Peer Comparison Metrics & Methodology

Earnings revisions for ALGER HEALTH have trended more positive than for its closest peers over the last 90 days. When ALGER HEALTH and a peer diverge sharply on valuation, the earnings and cash flow data usually explain why. Peer benchmarking can improve context for valuation without relying only on standalone multiples.

The analytics block for Alger Health Sciences relies on fund disclosures and market reference feeds, with quality checks and normalization applied before rendering. Timing can vary by data vendor.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board
Last reviewed on March 4th, 2026